Jeff Lubrano is currently the Enterprise Process Owner FP&A and ESG (SAP S/4HANA) at AstraZeneca, leading global initiatives in Planning & Management Reporting and ESG on the company's transformation program. They previously served as Head of R&D Finance at Alexion Pharmaceuticals from 2020 to 2024 and held various finance roles at Pfizer, GSK, and ViiV Healthcare, where they specialized in areas such as Gross to Net and International Finance. Jeff earned both a Master of Science in Management Information Systems and an MBA from the University of Pittsburgh Katz Graduate School of Business and holds a BA from The College of William and Mary.
This person is not in the org chart
This person is not in any teams
This person is not in any offices